Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis

The Lancet Diabetes and Endocrinology

Volumn 5, Issue 3, 2017, Pages 165-173

  Inge, Thomas H ^a   Jenkins, Todd M ^a   Xanthakos, Stavra A ^a   Dixon, John B ^c   Daniels, Stephen R ^b   Zeller, Meg H ^a   Helmrath, Michael A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN;

ADOLESCENT; ADOLESCENT OBESITY; ADULT; ANEMIA; ARTICLE; BARIATRIC SURGERY; BODY MASS; COMORBIDITY; DYSLIPIDEMIA; ELEVATED BLOOD PRESSURE; FEMALE; FOLLOW UP; GASTROINTESTINAL SURGERY; HUMAN; HYPERPARATHYROIDISM; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL DEFICIENCY; PROSPECTIVE STUDY; ROUX-EN-Y GASTRIC BYPASS; UNITED STATES; WEIGHT REDUCTION; CARDIOVASCULAR SYSTEM; CHILDHOOD OBESITY; CLINICAL TRIAL; GASTRIC BYPASS SURGERY; METABOLISM; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; BODY MASS INDEX; CARDIOVASCULAR SYSTEM; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; HUMANS; MALE; PEDIATRIC OBESITY; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85008627421     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(16)30315-1     Document Type: Article

References (32)

1. 1 Skinner, AC, Perrin, EM, Skelton, JA, Prevalence of obesity and severe obesity in US children, 1999–2014. Obesity (Silver Spring) 24 (2016), 1116–1123.
2. 2 Twig, G, Yaniv, G, Levine, H, et al. Body-mass index in 2·3 million adolescents and cardiovascular death in adulthood. N Engl J Med 374 (2016), 2430–2440.
3. 3 Kelly, AS, Barlow, SE, Rao, G, et al. Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches—a scientific statement from the American Heart Association. Circulation 128 (2013), 1689–1712.
4. 4 Inge, TH, Boyce, TW, Lee, M, et al. Access to care for adolescents seeking weight loss surgery. Obesity (Silver Spring) 22 (2014), 2593–2597.
5. 5 Inge, TH, Jenkins, TM, Zeller, M, et al. Baseline BMI is a strong predictor of nadir BMI after adolescent gastric bypass. J Pediatr 156 (2010), 103–108 e1.
6. 6 Miyano, G, Jenkins, TM, Xanthakos, SA, Garcia, VF, Inge, TH, Perioperative outcome of laparoscopic Roux-en-Y gastric bypass: a children's hospital experience. J Pediatr Surg 48 (2013), 2092–2098.
7. 7 Inge, TH, Courcoulas, AP, Jenkins, TM, et al. Weight loss and health status 3 years after bariatric surgery in adolescents. N Engl J Med 374 (2016), 113–123.
8. 8 Childerhose, JE, Tarini, BA, Understanding outcomes in adolescent bariatric surgery. Pediatrics 136 (2015), e312–e314.
9. 9 Daniels, SR, Kelly, AS, Pediatric severe obesity: time to establish serious treatments for a serious disease. Child Obes 10 (2014), 283–284.
10. 10 Jenkins, TM, Xanthakos, SA, Zeller, MH, Barnett, SJ, Inge, TH, Distance to clinic and follow-up visit compliance in adolescent gastric bypass cohort. Surg Obes Relat Dis 7 (2011), 611–615.
11. 11 Inge, TH, Krebs, NF, Garcia, VF, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics 114 (2004), 217–223.
12. 12 Zou, G, A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 159 (2004), 702–706.
13. 13 Lawson, ML, Kirk, S, Mitchell, T, et al. One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: a multicenter study from the Pediatric Bariatric Study Group. J Pediatr Surg 41 (2006), 137–143.
14. 14 van der Baan-Slootweg, O, Benninga, MA, Beelen, A, et al. Inpatient treatment of children and adolescents with severe obesity in the Netherlands: a randomized clinical trial. JAMA Pediatr 168 (2014), 807–814.
15. 15 Inge, TH, Siegel, RM, Xanthakos, SA, Weight loss maintenance: a hard nut to crack. JAMA Pediatr 168 (2014), 796–797.
16. 16 Marcus, MD, Foster, GD, El Ghormli, L, Stability of relative weight category and cardiometabolic risk factors among moderately and severely obese middle school youth. Obesity (Silver Spring) 22 (2014), 1118–1125.
17. 17 Danielsson, P, Kowalski, J, Ekblom, O, Marcus, C, Response of severely obese children and adolescents to behavioral treatment. Arch Pediatr Adolesc Med 166 (2012), 1103–1108.
18. 18 Freedman, DS, Mei, Z, Srinivasan, SR, Berenson, GS, Dietz, WH, Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Pediatr 150 (2007), 12–17 e2.
19. 19 Rank, M, Siegrist, M, Wilks, DC, et al. The cardio-metabolic risk of moderate and severe obesity in children and adolescents. J Pediatr 163 (2013), 137–142.
20. 20 McGill, HC Jr, McMahan, CA, Zieske, AW, Malcom, GT, Tracy, RE, Strong, JP, Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile. Circulation 103 (2001), 1546–1550.
21. 21 TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 366 (2012), 2247–2256.
22. 22 TODAY Study Group. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care 36 (2013), 1735–1741.
23. 23 Kim, J, Eisenberg, D, Azagury, D, Rogers, A, Campos, GM, American Society for Metabolic and Bariatric Surgery position statement on long-term survival benefit after metabolic and bariatric surgery. Surg Obes Relat Dis 12 (2016), 453–459.
24. 24 Mingrone, G, Panunzi, S, De Gaetano, A, et al. Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 386 (2015), 964–973.
25. 25 August, GP, Caprio, S, Fennoy, I, et al. Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab 93 (2008), 4576–4599.
26. 26 Pratt, JS, Lenders, CM, Dionne, EA, et al. Best practice updates for pediatric/adolescent weight loss surgery. Obesity (Silver Spring) 17 (2009), 901–910.
27. 27 Michalsky, M, Reichard, K, Inge, T, et al. ASMBS pediatric committee best practice guidelines. Surg Obes Relat Dis 8 (2012), 1–7.
28. 28 National Institute of Diabetes and Digestive and Kidney Diseases. Potential candidates of bariatric surgery. https://www.niddk.nih.gov/health-information/health-topics/weight-control/bariatric-surgery/Pages/potential-candidates.aspx, July, 2016 (accessed Aug 1, 2016).
29. 29 Bruno, C, Fulford, AD, Potts, JR, et al. Serum markers of bone turnover are increased at six and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin. J Clin Endocrinol Metab 95 (2010), 159–166.
30. 30 Grethen, E, Hill, KM, Jones, R, et al. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. J Clin Endocrinol Metab 97 (2012), 1655–1662.
31. 31 Modi, AC, Zeller, MH, Xanthakos, SA, Jenkins, TM, Inge, TH, Adherence to vitamin supplementation following adolescent bariatric surgery. Obesity (Silver Spring) 21 (2013), E190–E195.
32. 32 Patient-Centered Outcomes Research Institute. PCORnet Bariatric Study. http://www.pcori.org/research-results/2015/pcornet-bariatric-study (accessed Oct 27, 2016).